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Background: Listeriosis caused by Listeria monocytogenes has a high case-fatality rate 
(CFR) of approximately 20% to 30%. An increasing incidence of listeriosis has been re-
ported in many countries recently. We investigated the annual incidence, clinical charac-
teristics, and outcomes of listeriosis at three different hospitals in Korea and evaluated the 
effects of appropriate empiric antimicrobial treatments on patient outcomes.
Methods: We retrospectively collected the data of all culture-positive cases of human liste-
riosis from three hospitals of different sizes in Korea during 2006–2016 and calculated the 
annual number of cases and incidence per 100,000 admissions. 
Results: A total of 58 patients with L. monocytogenes were included in this study. The in-
cidence of listeriosis was significantly higher in 2013–2016 than in 2006–2012 (RR 3.1; 
95% CI 1.79–5.36; P <0.001), mainly because of an increase in patients over 60 years of 
age (RR 3.69; 95% CI 1.70–8.02; P <0.001). Multivariate analysis showed that health-
care-associated infection (adjusted OR, 12.15; 95% CI, 2.56–86.01; P =0.004) and em-
pirical treatment with first-line antimicrobial agents (adjusted OR, 0.08; 95% CI, 0.00–
0.63; P =0.044) were associated with CFR. 
Conclusions: Healthcare-associated infections caused by L. monocytogenes are associ-
ated with high CFR. Adequate initial empirical treatments could reduce CFR, suggesting 
that careful consideration of an empirical antimicrobial regimen is warranted for elderly or 
immunocompromised patients admitted to the hospital.
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INTRODUCTION
Listeriosis caused by Listeria monocytogenes is a bacterial in-
fection with a high case-fatality rate (CFR) of approximately 20% 
to 30%; listeriosis occurs mainly in the elderly, neonates, immu-
nocompromised patients, and pregnant women via central ner-
vous system (CNS) infection and bloodstream infection (BSI) [1-
4]. This gram-positive intracellular bacterium is widespread in 
the natural environment [5], and infections mostly arise follow-
ing the consumption of contaminated food, such as unheated 
ready-to-eat meals and dairy products [6-8], because of the abil-
ity of L. monocytogenes to survive under salty or acidic condi-
tions and grow at refrigeration temperatures [9].
An increase in the annual incidence of listeriosis has been re-
ported in many countries recently [1, 7, 10-12]. Although a num-
ber of listeriosis outbreaks have been reported [13], most cases 
are sporadic. In addition, there is an increasing concern regard-
ing the emergence of healthcare-associated listeriosis [11]. How-
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ever, L. monocytogenes infection is difficult to diagnose and treat 
with appropriate initial empiric treatments because it does not 
produce any specific symptoms [14].
Large-scale multilocus sequence typing (MLST) has been per-
formed in a number of European countries to investigate the gen-
otype-related characteristics of strains [1, 4, 6, 15]. However, 
only a few groups have performed MLST studies of L. monocy-
togenes in Asian countries [16], and the available data is too 
limited for comparisons with other regions. 
We investigated the annual incidence, clinical characteristics, 
and outcomes of listeriosis at three different hospitals in Korea 
and evaluated the effects of appropriate empiric antimicrobial 
treatments on patient outcomes. In addition, we analyzed MLST 
profiles of a subset of L. monocytogenes isolates to determine 
which strains caused outbreaks and compared our data with 
the results of previous studies. We aimed to determine whether 
listeriosis incidence increased in Korea and to analyze the risk 
factors associated with treatment outcome.
METHODS
We retrospectively collected the data pertaining to all culture-
positive cases of human listeriosis from three hospitals of differ-
ent sizes (38 cases from hospital “A” [>2,000 beds; tertiary 
university hospital, Seoul], 10 cases from hospital “B” [>800 
beds; tertiary university hospital, Seoul], and 10 cases from hos-
pital “C” [>700 beds; secondary national hospital, Goyang]) in 
Korea during 2006–2016 and calculated the annual number of 
cases and incidence per 100,000 admissions at the three hos-
pitals. We excluded duplicate cases.
The following clinical data were collected from electronic medi-
cal records: age at diagnosis, sex, underlying diseases, date of 
patient death or most recent visit, sampling sites, date of sample 
collection and report of culture results, and any antimicrobial 
agents administered during hospitalization. Available laboratory 
findings at the time of sample collection, including C-reactive 
protein (CRP) level, erythrocyte sedimentation rate (ESR), white 
blood cell (WBC) count, neutrophil percent, and antimicrobial 
susceptibility test results, were also obtained.
We performed MLST analysis for 19 isolates collected from 
hospital “A”, as described by Ragon et al [6]. The sequences of 
seven housekeeping genes (abcZ, bglA, cat, dapE, dat, ldh, and 
lhkA) were analyzed, and the sequence type (ST) and clonal 
complex (CC) of the obtained data were assigned using the Lis-
teria MLST database hosted by the Institut Pasteur (http://big-
sdb.pasteur.fr/listeria).
This retrospective study was approved by the Institutional Re-
view Board at Shinchon and Gangnam Severance Hospital (Seoul, 
Korea) and the National Health Insurance Service of Ilsan Hos-
pital (Goyang, Korea).
1. Definitions
Cases were categorized as CNS infections, BSIs, pregnancy-as-
sociated infections, or other infections based on the site of isola-
tion of L. monocytogenes and clinical diagnosis. Pregnancy-as-
sociated infections were defined as listeriosis in <30-day-old 
newborn infants with maternal-fetal infections. 
The presence of the following immunocompromised condi-
tions was documented: solid organ cancer, hematologic malig-
nancy, type 2 diabetes mellitus (DM), chronic kidney disease, 
chronic respiratory disease, chronic liver disease, stroke, and 
autoimmune disease treated with corticosteroids.
The term CFR refers to non-pregnancy associated mortality 
within 30 days of the sample collection date.
Listeriosis was considered to be ‘healthcare-associated’ if (a) 
the onset of listeriosis symptoms occurred 48 hours post admis-
sion and there was no evidence of infection at admission; if (b) 
infections were acquired at other hospitals prior to transfer to 
the study hospitals; or if (c) infections were acquired during a 
previous admission within two weeks of presentation. Otherwise, 
listeriosis was considered to be community-associated, as previ-
ously reported [17, 18].
Antimicrobial agents were categorized into three groups: first-
line antimicrobial agents, defined as monotherapy or combina-
tions of penicillin or ampicillin and gentamicin; alternative anti-
microbial agents including trimethoprim-sulfamethoxazole, eryth-
romycin (excluding ineffective use for pregnancy-associated in-
fections) [19], vancomycin (excluding ineffective use for CNS 
infections) [20], imipenem, or meropenem; and other drugs clas-
sified as inadequate antimicrobial agents [10].
2. Statistical analysis
Incidence rates ratios (RRs) and 95% confidence intervals (CI) 
were calculated by comparing the mean incidence between 
2006–2013 and 2014–2016. 
In all variables included in the statistical analysis, we assessed 
whether they followed a Gaussian distribution using the Shapiro-
Wilks test. We described the case characteristics using medians 
and interquartile ranges (IQRs). The significance of the differ-
ences between groups was tested with Fisher’s exact test for 
qualitative data and the Mann-Whitney U test for quantitative 
data. 
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To obtain odds ratios (ORs), univariate and multivariate re-
gressions were performed using logistic regression. Dependent 
variables included in the multivariate regressions were selected 
using Akaike’s information criterion (AIC) based on forward step-
wise logistic regression. The presence of variance inflation fac-
tors was also examined for all parameters of the multiple regres-
sion models. 
All reported P values are two-tailed, and P values <0.05 were 
considered to indicate statistical significance. All statistical anal-
yses were performed using the R statistical software (Version 
0.99.893— 2009–2016; R Studio, Boston, MA, USA).
 
Fig. 1. Increase in the number of Listeria monocytogenes isolates 
according to age distribution, 2006–2016.
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Fig. 2. Trends in non-pregnancy-associated listeriosis categorized by (A) age distribution and (B) underlying disease, 2006–2012 vs 2013–
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Abbreviations: Postop, postoperative states; HM, hematologic malignancies; DM, diabetes mellitus; CRD, chronic respiratory diseases; CLD, chronic liver dis-
eases; CKD, chronic kidney diseases.
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RESULTS
Although the annual incidence of listeriosis was stable from 2006–
2012, it has increased since 2013 (Fig. 1). The incidence of lis-
teriosis was significantly higher in 2013–2016 than in 2006–
2012 (RR 3.1; 95% CI 1.79–5.36; P <0.001), mainly because 
of the increase in patients >60 years of age (RR 3.69; 95% CI 
1.70–8.02; P <0.001) and those with underlying diseases such 
as solid organ cancer and DM (Fig. 2). 
Table 1 describes the clinical characteristics of cases by year. 
No statistically significant differences were observed in patient 
sex, infection type, isolate source, or CFR. Fig. 2 illustrates the 
increased annual incidence of three groups: pregnancy-associ-
ated infections, patients >60 years of age, and patients <60 
years of age. There was no significant difference in pregnancy-
associated infections; however, the incidence of patients >60 
years of age increased.
The median age of all 58 patients was 62 years (IQR, 52–72 
years). Thirty-one (53.4%) patients were males. Patient demo-
graphic and baseline characteristics according to community- 
and healthcare-associated infections are summarized in Table 2. 
Forty-two cases were classified as community-associated infec-
tion, and 16 cases were classified as healthcare-associated in-
fection. Of the infections, 58.6% were BSIs, 25.9% were CNS 
infections, 8.6% were pregnancy-associated infections, and 
6.9% consisted of other infections such as peritonitis (three of 
four cases) and pneumonia (one of four cases). Inadequate an-
timicrobial agents were most frequently observed in initial em-
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piric treatment (60.3%), and first-line antimicrobial agents were 
selected in 31% (18 of 58) of cases; treatment regimen was 
mostly altered to first-line antimicrobial agents after obtaining 
culture results (median delay of 0 day; IQR, 0–2 days). All 14 
isolates tested for antimicrobial susceptibility were susceptible 
to ampicillin, whereas only two of the 39 isolates showed resis-
tance to trimethoprim-sulfamethoxazole and four of the 39 iso-
lates were resistant to penicillin. There were no statistically sig-
nificant differences between the community- and healthcare-
associated infection groups in terms of median age at diagnosis, 
sex, or infection type. Of the non-pregnancy associated cases, 
17 patients died within 30 days of sample collection. The health-
care-associated infection group showed a higher mortality rate 
than the community-associated infection group (56.2% vs 21.6%, 
P =0.014). 
MLST analysis of 19 available L. monocytogenes isolates from 
hospital “A” revealed that seven isolates belonged to genetic lin-
eage I and 12 isolates belonged to genetic lineage II and that 
there were 13 different sequence types (ST) present (Table 3). 
The remaining 39 isolates had not been frozen and therefore 
could not be analyzed. The most commonly identified genotype 
was ST9 (four isolates), followed by ST7, ST1, and ST2 (two iso-
lates each). No dominant sequence type was apparent. 
Variables associated with CFR are described in Table 4. Uni-
variate analysis showed that healthcare-associated infection was 
associated with CFR (OR, 5.51; 95% CI, 1.57–21.04; P =0.0093). 
Multivariate analysis showed that healthcare-associated infec-
tion (adjusted OR, 12.15; 95% CI, 2.56–86.01; P =0.004) and 
empirical treatment with first-line antimicrobial agents (adjusted 
OR, 0.08; 95% CI, 0.00–0.63; P =0.044) were associated with 
CFR. 
DISCUSSION
Human listeriosis is a rare disease; however, its incidence has 
increased in recent years in many countries [1, 15, 21]. Our 
data also demonstrated a significant increase of listeriosis at 
three Korean hospitals since 2013. It was mainly due to an in-
crease in patients over the age of 60 years and patients in an 
immunocompromised state due to conditions such as solid or-
gan cancer or type 2 DM. 
Listeriosis exhibited a high CFR (29.3%) in our study. Using 
multivariate analysis, we found that healthcare-associated infec-
tions constitute a risk factor related to higher CFR compared 
with community-associated infections. In addition, the initial se-
lection of appropriate empiric antimicrobial agents was associ-Ta
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ated with a low CFR. Therefore, initial empiric treatment should 
be chosen carefully in patients with healthcare-associated liste-
riosis. 
However, it is difficult to select an adequate initial regimen 
because listeriosis does not present with any specific symptoms, 
and many classes of antimicrobial agents that are widely used 
Table 2. Baseline characteristics of patients with listeriosis
Total
(N=58)
Community-associated 
infection
(N=42)
Healthcare-associated 
infection
(N=16)
P 
Age (yr) 62.0 [52.0–72.0] 62.0 [47.0–72.0] 61.0 [55.0–70.0] 0.754
Male sex 31 (53.4) 20 (47.6) 11 (68.8) 0.251
Infection type 0.396
   BSI 34 (58.6) 24 (57.1) 10 (62.5)
   CNS 15 (25.9) 11 (26.2) 4 (25.0)
   Pregnancy-associated 5 (8.6) 5 (11.9) 0 (0.0)
   Other 4 (6.9) 2 (4.8) 2 (12.5)
CFR 17 (29.3) 8 (21.6) 9 (56.2) 0.014
Culture results report time post sample collection (day) 3.0 [2.0–4.0] 3.0 [2.0–4.0] 3.0 [2.0–6.0] 0.404
Duration of inadequate antimicrobial treatment (day) 2.0 [0.0–4.0] 2.5 [0.0–4.0] 2.0 [0.0–3.5] 0.605
Underlying disease 0.270
   Solid cancer 24 (41.4) 14 (33.3) 10 (62.5)
   Hematologic malignancy 3 (5.2) 2 (4.8) 1 (6.2)
   Other immunocompromised conditions 22 (37.9) 17 (40.5) 5 (31.2)
   Pregnancy-associated 5 (8.6) 5 (11.9) 0 (0.0)
   Other 4 (6.9) 4 (9.5) 0 (0.0)
Laboratory findings
   C reactive protein (mg/L)     52.1 [16.4–176.9]     66.1 [14.1–164.4]     35.5 [20.3–229.8] 0.515
   Erythrocyte sedimentation rate (mm/hr)   48.5 [15.0–71.0]   48.5 [22.0–71.0]   32.5 [11.5–71.5] 0.586
   WBC count (109/L) 11.1 [4.9–17.1] 12.3 [4.9–17.8] 10.3 [5.4–13.4] 0.439
   Neutrophils (%)   86.0 [77.0–91.5]   86.0 [74.4–91.5]   86.1 [81.2–91.7] 0.638
Initial empiric treatments 0.339
   First-line antimicrobial agents* 18 (31.0) 13 (31.0) 5 (31.2)
   Alternative antimicrobial agents† 5 (8.6) 5 (11.9) 0 (0.0)
   Inadequate antimicrobial agents 35 (60.3) 24 (57.1) 11 (68.8)
Treatments post bacterial identification 0.650 
   First-line antimicrobial agents* 39 (67.2) 27 (64.3) 12 (75.0)
   Alternative antimicrobial agents† 7 (12.1) 6 (14.3) 1 (6.2)
   Inadequate antimicrobial agents 12 (20.7) 9 (21.4) 3 (18.8)
Antibiotic susceptibility test (n-%susceptibility)
   Ampicillin 14 (100.0) 8 (100.0) 6 (100.0) 0.593
   Penicillin 35 (89.7) 24 (85.7) 11 (100.0) 0.461
   Trimethoprim-sulfamethoxazole 37 (94.9) 28 (96.6) 9 (90.0) 0.194
Data are presented as numbers (%) or medians [interquartile range].
*First-line antimicrobial agents: ampicillin or penicillin alone or in combination with gentamicin; †Alternative antimicrobial agents: trimethoprim-sulfamethox-
azole, imipenem, meropenem, or vancomycin (excluding use in CNS infection).
Abbreviations: CFR, case-fatality rate; BSI, blood stream infection; CNS, central nervous system; WBC, white blood cell.
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Table 3. Available MLST test results for Listeria monocytogenes iso-
lates 
N ST/CC Genetic lineage Year(s)
4 9/9 II 2014–2016
2 7/7 II 2011, 2014
2 1/1 I 2014, 2016
2 59/59 I 2016
1 224/224 I 2009
1 91/14 II 2011
1 101/101 II 2013
1 121/121 II 2013
1 8/8 II 2014
1 5/5 I 2015
1 87/87 I 2016
1 18/18 II 2016
1 155/155 II 2016
Abbreviations: MLST, multilocus sequence typing; ST, sequence type; CC, 
clonal complex.
Table 4. Results of univariate and multivariate analyses of risk factors for case-fatality due to Listeriosis 
Variables
Survived
(N=37)
Died||
(N=16)
Univariate analysis Multivariate analysis
OR (95% CI) P OR (95% CI) P 
Age (≥60 yr)* 15 (40.5) 7 (43.8) 1.14 (0.34–3.74) 0.828 
Sex, female* 16 (43.2) 8 (50.0) 1.31 (0.40–4.32) 0.650 
Healthcare-associated infection* 7 (18.9) 9 (56.2) 5.51 (1.57–21.04) 0.009 12.15 (2.56–86.01)† 0.004
Immunocompromised state* 33 (89.2) 16 (100.0) NA
Prior history of solid organ or hematologic malignancy* 16 (43.2) 11 (68.8) 2.89 (0.87–10.75) 0.094 
Bacterial identification report time post sample collection (+1 day) 3.0 [2.0–4.0] 3.0 [2.0–3.5] 0.81 (0.53–1.14) 0.279 0.67 (0.41–1.01)† 0.0674
Duration of inadequate antibiotic treatment (+1 day) 4.0 [2.0–6.0] 3.0 [3.0–5.0] 1.06 (0.82–1.34) 0.650 
Infection type*
   BSI 25 (67.6) 9 (56.2) 1.0 
   CNS 11 (29.7) 4 (25.0) 0.79 (0.19–2.86) 0.726 
   Other 1 (2.7) 3 (18.8) 8.31 (0.97–176.48) 0.078 
Initial empiric treatment*
   First-line antimicrobial agents‡ 12 (32.4) 2 (12.5) 0.14 (0.01–0.85) 0.074 0.08 (0.00–0.63)† 0.044
   Alternative antimicrobial agents§ 3 (8.1) 2 (12.5) 1.13 (0.14–7.70) 0.902 
   Inadequate regimens 22 (59.5) 12 (75.0) 1.0 
Treatment following bacterial identification*
   First-line antimicrobial agents‡ 27 (73.0) 9 (56.2) 0.58 (0.14–2.65) 0.464 
   Alternative antimicrobial agents§ 3 (8.1) 3 (18.8) 1.75 (0.23–14.22) 0.587 
   Inadequate antimicrobial agents 7 (18.9) 4 (25.0) 1.0 
Data are presented as numbers (%) or medians [interquartile range].
*Categorical variables included in logistic regression; †Variables included in the multivariable model were selected using the Akaike’s Information Criterion 
(AIC) value based on forward stepwise logistic regression (AIC=56.046); ‡First-line antimicrobial agents: ampicillin or penicillin alone or in combination with 
gentamicin; §Alternative antimicrobial agents: trimethoprim-sulfamethoxazole, imipenem, meropenem, or vancomycin (excluding use in CNS infection); llIn-
cluded non-pregnancy associated mortality within 30 days of the sample collection date.
Abbreviations: OR, odds ratio; CI, confidence interval; NA, not available; BSI, blood stream infection; CNS, central nervous system.
in clinical settings, such as cephalosporins [15] and quinolones 
[22], are not effective against L. monocytogenes infection. In 
our study, only 18 of 58 (31.0%) patients were treated initially 
with ampicillin- or penicillin-based regimens, whereas 35 pa-
tients (60.3%) were treated with inadequate empirical regimens, 
including cephalosporins (18 patients, 27.6%), quinolones (nine 
patients, 15.5%) and no empirical antibiotics (eight patients, 
13.8%). Although 24 of 35 patients who received inadequate 
initial empirical regimens were immediately changed over to ad-
equate drugs (median, 2.0 day), such as ampicillin or penicillin 
once culture results were obtained, this was not reflected by a 
statistically significant difference in CFR. 
A previous meta-analysis has suggested that L. monocyto-
genes should not be considered in febrile infants because of the 
very rare incidence of listeriosis at that age [23]. In addition, the 
annual incidence of pregnancy-associated listeriosis has decre-
ased significantly since 1985, presumably because of preven-
Choi MH, et al.
Increasing incidence of listeriosis in Korea
108  www.annlabmed.org https://doi.org/10.3343/alm.2018.38.2.102
tive campaigns aimed at pregnant women [24-26]. However, an 
increased incidence of listeria in adults over 60 years of age has 
been reported in several studies [1, 15, 27]. Therefore, the ini-
tial empiric treatment against L. monocytogenes, especially in 
healthcare-associated infections, should be carefully considered 
in groups at high-risk for listeriosis such as elderly and immuno-
compromised patients.
Because no major STs were found in the MLST analysis, the 
increased incidence we observed was likely due to sporadic cases 
rather than an outbreak. We compared the STs of L. monocyto-
genes obtained by MLST with those reported in previous studies 
in other countries [28, 29]. CC8 was a major global L. monocy-
togenes isolate because of its high biofilm forming capacity and 
its ability to persist in food industrial processes and subsequently 
contaminate food [30]. According to our results, only one of the 
19 isolates was identified as CC8, while the most common ST 
(four of 19 isolates) was CC9, consistent with the frequency de-
scribed by Cantinelli et al [28]. The fact that CC8 was not the 
major ST in our study may be due to differences in regional or 
dietary habits in Korea.
Our study had a number of limitations. It was a retrospective 
study, and only 19 of 58 isolates were subjected to MLST analy-
sis, which could have biased the results and decreased the like-
lihood of identifying major type isolates. In addition, several im-
portant medical record details, such as infection source of liste-
riosis, were not available for most patients. However, although 
human listeriosis is a food-borne disease, it is difficult to deter-
mine the food source of infection because of the long incuba-
tion time of L. monocytogenes [7].
This study demonstrated an increased incidence of listeriosis 
in elderly patients and those in an immunocompromised state 
at three Korean hospitals. Healthcare-associated infections caused 
by L. monocytogenes were associated with a high CFR and ad-
equate initial empirical treatments appeared to reduce CFR, sug-
gesting that careful consideration of the empirical antimicrobial 
regimen for elderly or immunocompromised patients admitted 
to the hospital is warranted. Multi-center, prospective studies in-
cluding a larger number of patients with listeriosis would help 
support our recommendations concerning careful initial empiric 
treatment of healthcare-associated infections.
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